Breaking News, Collaborations & Alliances

InNexus Biotech, Affirmed Therapeutics

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

InNexus Biotechnology and Affimed Therapeutics have formed a collaboration utilizing Affimed’s antibodies and InNexus’ SuperAntibody antibody enhancement drug development platform. The companies will complete feasibility studies and InNexus will have a right to license one of Affimed’s antibodies, while Affimed will have the right to license SuperAntibody Technology for one antibody. Exercise-of-rights is expected to trigger payments in the form of licensing fees, milestone pay...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters